Related Experiment Video
Updated: May 16, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
Geranylgeranylacetone protects against morphine-induced hepatic and renal damage in mice
Fu-Cheng Luo1, Lu Zhao, Juan Deng
1Medical Faculty, Kunming University of Science and Technology, Kunming 650500, P.R. China.
Abstract:
The acute or chronic administration of opioid drugs may induce oxidative damage and cellular apoptosis in the liver and kidney, and hence result in hepatic and renal damage. Thioredoxin-1 (Trx-1) and heat shock protein 70 (Hsp70) are emerging as important modulators of cellular functions. They have been shown to be involved in cellular protective mechanisms against a variety of toxic stressors. The present study was designed to investigate the effects of geranylgeranylacetone (GGA), a pharmacological inducer of Trx-1 and Hsp70, on morphine-induced hepatic and renal damage. Morphine induced apoptosis in the liver and kidney through the mitochondria-mediated apoptosis pathway, but not the endoplasmic reticulum-mediated pathway. The activation of caspases-9 and -3 was attenuated by pre‑treatment with GGA. In addition, the morphine-induced increase of malondialdehyde (MDA) levels was suppressed by GGA. Furthermore, GGA enhanced morphine-induced expression of Trx-1 and Hsp70 in the liver and kidney. The findings of this study suggest that GGA may be a safe and novel therapeutic agent for morphine‑induced hepatic and renal damage.
Insights
Geranylgeranylacetone (GGA) protects against morphine-induced liver and kidney damage by reducing apoptosis and oxidative stress. GGA enhances protective proteins thioredoxin-1 (Trx-1) and heat shock protein 70 (Hsp70).
Area of Science:
- Pharmacology
- Toxicology
- Cell Biology
Background:
- Opioid drugs, like morphine, can cause liver and kidney damage through oxidative stress and apoptosis.
- Thioredoxin-1 (Trx-1) and heat shock protein 70 (Hsp70) are key cellular protectors against various toxins.
- Geranylgeranylacetone (GGA) is known to induce Trx-1 and Hsp70 expression.
Purpose of the Study:
- To investigate the protective effects of GGA against morphine-induced hepatic and renal damage.
- To determine if GGA modulates apoptosis pathways and oxidative stress markers.
- To examine GGA's influence on Trx-1 and Hsp70 expression in the context of morphine toxicity.
Main Methods:
- Morphine was administered to induce liver and kidney damage.
- Pre-treatment with GGA was used to assess its protective potential.
- Apoptosis pathways (mitochondria-mediated and ER-mediated) were analyzed.
- Levels of malondialdehyde (MDA), a marker of oxidative damage, were measured.
- Expression of Trx-1 and Hsp70 was quantified.
Main Results:
- Morphine induced liver and kidney apoptosis via the mitochondria-mediated pathway.
- GGA pre-treatment attenuated the activation of caspases-9 and -3, key apoptotic enzymes.
- GGA suppressed the increase in malondialdehyde (MDA) levels caused by morphine.
- GGA enhanced the expression of Trx-1 and Hsp70 in response to morphine exposure.
Conclusions:
- GGA demonstrates protective effects against morphine-induced hepatic and renal damage.
- The protective mechanism involves the inhibition of apoptosis and oxidative stress.
- GGA's ability to induce Trx-1 and Hsp70 contributes to its therapeutic potential.
- GGA may serve as a novel therapeutic agent for opioid-induced organ damage.
Related Concept Videos
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Analgesia and Pain Management

